Navigation Links
Neuralstem, Inc. Settles Litigation Against ReNeuron, Ltd.
Date:1/28/2011

Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  The company has been approved to commence a Phase Ia safety trial evaluating NSI-189, its first small molecule compound, for the treatment of major depression.  Additional indications could include schizophrenia, Alzheimer's disease, traumatic brain injury, posttraumatic stress syndrome, and stroke.

For more information, please go to www.neuralstem.com

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annual report on Form 10-K for the year ended December 31, 2009, and in its quarterly report on Form 10-Q for the period ended September 30, 2010.


'/>"/>
SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
2. Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.
4. Celsis IVT Settles LiverPool Patent Infringement Suit With XenoTech, LLC
5. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
6. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
7. Clarient Tender Offer Extended; Clarient Makes Additional Disclosures to Settle Litigation
8. Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against the Company And Certain of Its Subsidiaries
9. Taconics Litigation Contesting License Termination By Cellectis Is Dismissed
10. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
11. The Medical College of Wisconsin Adopts Quantros Event Manager(TM) and Claims Manager(TM) for Comprehensive Malpractice Litigation Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... and Queens, New York (PRWEB) October 02, 2014 ... is pleased to announce funding received to investigate ... in Alzheimer’s disease. A grant award from the ... on Aging (NIA), National Institutes of Health (NIH) ... Novel AD Therapeutics." The company also received a ...
(Date:10/2/2014)... California (PRWEB) October 02, 2014 ... Livermore National Laboratory (LLNL) a grant today to ... researchers to better understand how the brain works ... project is part of NIH's efforts to support ... Neurotechnologies) Initiative, a new research effort to revolutionize ...
(Date:10/2/2014)... and BRIDGEWATER, N.J. , Oct. 2, ... a leader in synthetic biology, and Amneal ... manufacturer by volume in the U.S., today announced ... (ECC) for a target active pharmaceutical ingredient (API).  ... of the collaboration is to develop a consistent, ...
(Date:10/1/2014)... 1, 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... and sale of high pressure-based sample preparation systems to ... been invited to present at the 2 nd ... , Poland.  The Conference will take place at the ... Richard T. Schumacher , President and CEO of PBI, ...
Breaking Biology Technology:Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 2Gismo Therapeutics Inc. Awarded Grants to Develop New Alzheimer's Disease Therapeutics 3NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 2NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 3NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 4Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 2Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 4
... Genetics ,™ Inc., an innovative molecular diagnostics company developing the ... it completed the initial closing of a $14 million Series ... OrbiMed Advisors , Safeguard Scientifics, Inc. (NYSE: ... Proceeds from this financing will be used to augment commercial ...
... Want a see-through cellphone you can wrap around your wrist? ... Rice University chemist James Tour, whose lab has developed transparent, ... Tour revealed today in a talk at the national ... Diego that the new type of memory could combine with ...
... Centrix, a Nevada-based biotech corporation, announced this week its development ... a term used in programming wearable TheraEX (TM) skin ... field that surrounds all life forms. When ... in its basic form, it embodies seven major layers powered ...
Cached Biology Technology:Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 2Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 3Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 4Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 5AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches 2
(Date:9/30/2014)... almost any aquatic environment on Earth, but when the ... pushed to the limit. The amount of time needed ... how different species cope in the future, reveals a ... published in the scientific journal Proceedings of the ... thanks to increasing levels of greenhouse gases in the ...
(Date:9/30/2014)... to know what goes wrong with your muscles because of ... what "normal" actually is. That,s where a new research report ... FASEB Journal comes in. In the report, a ... molecules that can help scientists "see" which genes are active ... found never-before-detected gene activity and that men have approximately 400 ...
(Date:9/30/2014)... (September 30, 2014) People who suffer from asthma ... to control their asthma besides properly taking medications and ... article in the Annals of Allergy, Asthma and ... of Allergy, Asthma and Immunology (ACAAI), asthma sufferers can ... lifestyle. The woman described in the Annals article improved ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Scientists identify which genes are active in muscles of men and women 2Asthma symptoms kicking up? Check your exposure to air pollution 2
... requirements of new names for algae, fungi and plants ... Melbourne in July 2011 initiated several important challenges to scientists, ... the Congress decisions, the open access journal PhytoKeys ... one each day for the first week of 2012, starting ...
... This release is available in German . ... this more often when kin or mates are present than ... evidence that they take the other group members, knowledge state ... Anthropology in Leipzig, Germany, and the University of St. Andrews, ...
... found that elderly people with higher levels of several vitamins ... performance on mental acuity tests and less of the brain ... produced just the opposite result. The study was among ... range of blood nutrient levels instead of basing findings on ...
Cached Biology News:Brave new world 2Brave new world 3I know something you don't know -- and I will tell you! 2Diet, nutrient levels linked to cognitive ability, brain shrinkage 2
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells...
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to amino acids 196-244 of E. coli YebU....
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
... Antibody to CRF The ... ovine CRF sequence that it ... fibres are found in the ... brain in colchicine treated 4% ...
Biology Products: